| Patent | Date |
|---|
Anti-nucleolin Agent-conjugated Nanoparticles
App 20220265867 - Bates; Paula J. ; et al. | 2022-08-25 |
Anti-nucleolin agent-conjugated nanoparticles
Grant 11,344,633 - Bates , et al. May 31, 2 | 2022-05-31 |
Compounds, compositions, methods for treating diseases, and methods for preparing compounds
Grant 11,208,379 - Grapperhaus , et al. December 28, 2 | 2021-12-28 |
Methods Of Inhibiting Or Treating Coronavirus Infection, And Methods For Delivering An Anti-nucleolin Agent
App 20210299156 - Bates; Paula J. ; et al. | 2021-09-30 |
Anti-nucleolin Agent-conjugated Nanoparticles As Radio-sensitizers And Mri And/or X-ray Contrast Agents
App 20200390904 - Malik; Mohammad Tariq ; et al. | 2020-12-17 |
Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents
Grant 10,857,237 - Malik , et al. December 8, 2 | 2020-12-08 |
Methods For Treating Diseases
App 20200108050 - BATES; Paula J. ; et al. | 2020-04-09 |
Compounds, Compositions, Methods For Treating Diseases, And Methods For Preparing Compounds
App 20200062703 - Grapperhaus; Craig A. ; et al. | 2020-02-27 |
Targeted Nanodroplet Emulsions For Treating Cancer
App 20190192686 - Malik; Mohammad Tariq ; et al. | 2019-06-27 |
Anti-nucleolin Agent-conjugated Nanoparticles As Radio-sensitizers And Mri And/or X-ray Contrast Agents
App 20180200385 - Malik; Mohammad Tariq ; et al. | 2018-07-19 |
Compositions and methods for modulating DNMT1 inhibitor activity
Grant 9,737,493 - Salipur , et al. August 22, 2 | 2017-08-22 |
Anti-nucleolin Agent-conjugated Nanoparticles
App 20170095562 - Bates; Paula J. ; et al. | 2017-04-06 |
Compounds, compositions, pharmaceutical compositions, and methods of use
Grant 9,492,428 - Hammond , et al. November 15, 2 | 2016-11-15 |
Anti-nucleolin agent-conjugated nanoparticles
Grant 9,452,219 - Bates , et al. September 27, 2 | 2016-09-27 |
Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the marker
Grant 9,383,364 - Bates , et al. July 5, 2 | 2016-07-05 |
Compositions And Methods For Modulating Dnmt1 Inhibitor Activity
App 20150238439 - Salipur; Francesca R. ; et al. | 2015-08-27 |
Compounds, Compositions, Pharmaceutical Compositions, And Methods Of Use
App 20150025129 - Hammond; Gerald B. ; et al. | 2015-01-22 |
Predictive Marker Of Dnmt1 Inhibitor Therapeutic Efficacy And Methods Of Using The Marker
App 20140329911 - Bates; Paula J. ; et al. | 2014-11-06 |
Method For The Diagnosis And Prognosis Of Malignant Diseases
App 20140220013 - Bates; Paula J. ; et al. | 2014-08-07 |
Anti-nucleolin Agent-conjugated Nanoparticles
App 20140170076 - Bates; Paula J. ; et al. | 2014-06-19 |
Therapeutic compounds
Grant 8,703,829 - Hammond , et al. April 22, 2 | 2014-04-22 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
Grant 8,648,051 - Miller , et al. February 11, 2 | 2014-02-11 |
Method for the diagnosis and prognosis of malignant diseases
Grant 8,586,717 - Bates , et al. November 19, 2 | 2013-11-19 |
Methods Of Increasing Macropinocytosis In Cancer Cells
App 20130065227 - Bates; Paula J. ; et al. | 2013-03-14 |
Therapeutic Compounds
App 20120329866 - Hammond; Gerald B. ; et al. | 2012-12-27 |
Therapeutic compounds
Grant 8,207,381 - Hammond , et al. June 26, 2 | 2012-06-26 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
Grant 8,114,850 - Trent , et al. February 14, 2 | 2012-02-14 |
Method For The Diagnosis And Prognosis Of Malignant Diseases
App 20120014942 - Bates; Paula J. ; et al. | 2012-01-19 |
Method for the diagnosis and prognosis of malignant diseases
Grant 8,029,784 - Bates , et al. October 4, 2 | 2011-10-04 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
App 20110178161 - Trent; John O. ; et al. | 2011-07-21 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
Grant 7,960,540 - Trent , et al. June 14, 2 | 2011-06-14 |
Method For The Detection Of Apoptosis
App 20110065121 - Bates; Paula J. ; et al. | 2011-03-17 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
App 20090326047 - Miller; Donald M. ; et al. | 2009-12-31 |
Methods And Products To Target, Capture And Characterize Stem Cells
App 20090226914 - Bates; Paula J. ; et al. | 2009-09-10 |
Method for the diagnosis and prognosis of malignant diseases
Grant 7,541,150 - Miller , et al. June 2, 2 | 2009-06-02 |
Method For The Diagnosis And Prognosis Of Malignant Diseases
App 20090017009 - Bates; Paula J. ; et al. | 2009-01-15 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
App 20080318887 - Trent; John O. ; et al. | 2008-12-25 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
App 20080318890 - Trent; John O. ; et al. | 2008-12-25 |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
App 20080318889 - Trent; John O. ; et al. | 2008-12-25 |
Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
App 20080318888 - Trent; John O. ; et al. | 2008-12-25 |
Therapeutic Compounds
App 20080188570 - Hammond; Gerald B. ; et al. | 2008-08-07 |
Method for the diagnosis and prognosis of malignant diseases
Grant 7,357,928 - Bates , et al. April 15, 2 | 2008-04-15 |
Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
Grant 7,314,926 - Miller , et al. January 1, 2 | 2008-01-01 |
Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
App 20050187176 - Bates, Paula J. ; et al. | 2005-08-25 |
Method for the diagnosis and prognosis of malignant diseases
App 20050053607 - Bates, Paula J. ; et al. | 2005-03-10 |
Method for the detection of apoptosis
App 20040132049 - Bates, Paula J. ; et al. | 2004-07-08 |
Method for the diagnosis and prognosis of malignant diseases
App 20030194754 - Miller, Donald M. ; et al. | 2003-10-16 |
| 